Table of Contents

company-logo

SynAct Pharma AB, through its subsidiary, SynAct Pharma ApS, develops medicines for acute deterioration in inflammatory diseases. The company is developing AP1189, a drug candidate for the treatment of rheumatoid arthritis and idiopathic membranous glomerulonephritis. It has a partnership with the University Of Örebro to study the reduction of inflammation in vascular disease. The company was founded in 2012 and is headquartered in Lund, Sweden.

SynAct Pharma Dividend Announcement

• SynAct Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on SynAct Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

SynAct Pharma Dividend History

SynAct Pharma Dividend Yield

SynAct Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing SynAct Pharma stock? Use our calculator to estimate your expected dividend yield:

SynAct Pharma Financial Ratios

P/E ratio-2.51
PEG ratio0.02
P/B ratio2.29
ROE-90.31%
Payout ratio0.00%
Current ratio3.88
Quick ratio4.95
Cash Ratio2.35

SynAct Pharma Dividend FAQ

Does SynAct Pharma stock pay dividends?
SynAct Pharma does not currently pay dividends to its shareholders.
Has SynAct Pharma ever paid a dividend?
No, SynAct Pharma has no a history of paying dividends to its shareholders. SynAct Pharma is not known for its dividend payments.
Why doesn't SynAct Pharma pay dividends?
There are several potential reasons why SynAct Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will SynAct Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While SynAct Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is SynAct Pharma a dividend aristocrat?
SynAct Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is SynAct Pharma a dividend king?
SynAct Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is SynAct Pharma a dividend stock?
No, SynAct Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy SynAct Pharma stocks?
To buy SynAct Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy SynAct Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.